NCT01352520: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
- State
- Under way
- Phase
- Phase 2
- People
- 79 taking part
- Started
- Jun 2011
- Primary completion
- 31 Jan 2028
- Arms
- SGN-35
- Results
- None posted
- 12 May 2011: Trial registered